LOADING
Tag: ivarmacitinib
Early Response to Ivarmacitinib Predicts Durable Outcomes in Atopic Dermatitis – Dermatology Advisor
August 17, 2026
Early Response to Ivarmacitinib Predicts Durable Outcomes in Atopic Dermatitis Dermatology Advisor Source link
chat_bubble0 Comment
visibility47 Views
Ivarmacitinib Proves Effective in Treating Moderate to Severe Atopic Dermatitis – Docwire News
May 30, 2025
Ivarmacitinib Proves Effective in Treating Moderate to Severe Atopic Dermatitis Docwire News Source link
chat_bubble0 Comment
visibility154 Views
Copy of – Reistone reports positive phase III results for ivarmacitinib in atopic dermatitis
November 22, 2022
Reistone Biopharma Co. Ltd. said both doses of the JAK1 inhibitor ivarmacitinib, tested against moderate to severe atopic dermatitis (AD) in a multinational phase III trial, met the study’s co-primary endpoints, delivering significant improvements on a common measure of disease severity vs. placebo. It’s the first National Class A new drug for AD that is […]
chat_bubble0 Comment
visibility449 Views